Short Summary - October 16.
Another wasted day for $SFLM
Short Summary - October 16.
Another wasted day for $SFLM with no upward progress due to moronic flippers continuing to put walked down asks up and allowing new interest to get in cheap under .0025.
Not only are people continuing to fail to cancel left over flip asks before the open but they also are blatantly undercutting asks that were already up by the previous close.
It's only a matter of time before they get caught having flipped shares they haven't managed to replace by the close to discover that $SFLM is OTC Pink Current before the next open.
In early trading, .0025 was up with only 1.1M left.
It looks like it was shorted down to .0020 through bids .0021> .0023 as shorts may have covered with an after hours 4.82M at 16:02:08.
Once we get the .0030+ break, the serious traders of $SFLM - those with 25M > 50M+ shares - should be able to get momentum going and by continually outbidding stopping low level flip people from getting back in.
Overall, 35M was traded - similar to the 39M traded in the same range on Friday.
Traders need to note that every 1M sold at .0024 instead of .01 is throwing away $7.6K in profit and throwing away $17.6K at .02!
The share structure was updated on September 12 - again with no change.
There has no been no change to the Unrestricted O/S in 349 days.
Latest Overview here - updated October 1, 2023:
Watch out for possible upgrade to OTC Pink Current before the open on Monday.
SFLMaven, Inc. (SFLM) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Revolutionizing Cancer Treatment: Immunofoco's Approach In the battle against B-cell malignancies, the old ways of doing things sometimes just don’t cut it, folks. Enter Immunofoco. At the recent Society for Immunotherapy of Cancer (SITC) 2026 meeting, they laid some ambitious cards on the table with their in vivo T-cell engager (TCE) delivery strategy. Engineering...
Continue Reading
Class Action Shadows AppLovin Over AI Promises What a tangled web AppLovin has woven for itself. Promises of rapid AI advancements and a slick video tool rollout seemed like a done deal back in the early months of 2026. Well, that was until the cracks started to show by August. Promises Made, Promises Broken The saga kicked off on May 6, 2026, with AppLovin's confident...
Continue Reading
A Nod to Legal Excellence In the world of labor and employment law, notches on the belt come from more than just winning cases. It's about mastering the balance between legal prowess and professional grace—a cocktail that Johnine P. Barnes seems to have perfected. Just this November, Barnes was elected as a fellow of the College of Labor & Employment Lawyers (CLEL), a...
Continue Reading
An Unforgettable Holiday Season Veterans Day isn't just a date on the calendar—it's an opportunity to pause and offer genuine thanks to those who've served with honor. This year, as the holiday season rolls around, Gemmy Industries' Claus for a Cause collection is redefining how we show our appreciation. These aren't your ordinary inflatables; they come with a purpose...
Continue Reading
The Hidden Dangers of Artificial Stone Here's the grim truth. Artificial stone countertops, loved by many for their aesthetics in kitchens and bathrooms, have a dark side that’s becoming increasingly hard to ignore. Loaded with more than 90% respirable crystalline silica, these materials spew out toxic dust when cut or polished. Once that dust gets airborne, workers...
Continue Reading
Earnings Are Around the Corner for Strauss Group This thing's been coming down the pipeline, and now it's official: Strauss Group Ltd. (TASE: STRS) is throwing open the curtain on its third quarter numbers come November 25, 2026. Mark the date, folks: it's a Wednesday. And in this game, timings matter a heap more than you'd think. With the financial world constantly...
Continue Reading
Tech Revolution in Porcelain's Traditional Hearth Imagine robots glazing porcelain and kilns all on autopilot—that's the new norm at Huairen City, Shanxi Province, home to China's formidable porcelain industry. Gone are the days when craftsmen relied solely on their keen senses to judge the right glaze and firing time. The latest technology has disrupted tradition here,...
Continue Reading
The Turbulence Behind FLNC: A Hard Pill to Swallow Looks like Fluence Energy (NASDAQ: FLNC) has stumbled right into a mess that's leaving investors with a bitter aftertaste. A securities class action lawsuit has been thrown their way, shaking up any stability folks thought they had. Levi & Korsinsky, LLP laid down the gauntlet on behalf of the shareholders hoodwinked by...
Continue Reading
Venturing into Hospitality Real Estate If you're in the hospitality game, the question of whether to buy or to lease your property can loom like a shadow or shine like an opportunity. The latest episode of the Owner's Edge Podcast by Bielat Santore & Company dives into this headfirst, armed with over 45 years of brokering experience in hospitality transactions. They don't...
Continue Reading
Global Tanker Market Challenges Drive Earnings The energy shipping scene's got some heat this quarter, my friends. With crude oil prices getting a decent lift today, some energy shipping players are riding that wave to pretty stellar quarterly results. For those in the know, the global tanker market's choking a bit, making for tight conditions. And when the screws...
Continue Reading
Top 5 Most Recently Viewed Articles
Investors Assess the Options Market for Riot Platforms In today’s trading environment, investors have embraced a pessimistic outlook on Riot Platforms (NASDAQ: RIOT). This comes as no surprise given the substantial movements detected in the options market, indicating that something notable might be on the horizon for Riot. The notable activity is significant, showcasing...
Continue Reading
Herantis Pharma Celebrates Positive Outcomes in Parkinson’s Trial Herantis Pharma has made substantial strides in its quest to develop effective therapies for those living with Parkinson’s disease. The company recently shared exciting topline results from its Phase 1b trial conducted with HER-096, a promising candidate designed to tackle the challenges of this...
Continue Reading
Beezie Redefines the Collectibles Resale Game In an exciting development within the collectibles market, Beezie is pioneering new approaches to how resellers manage and sell high-value items like trading cards, sneakers, and memorabilia. With its innovative platform, Beezie has introduced gamification and secure vaulting, setting a new standard in the industry....
Continue Reading
Investigating Potential Claims for agilon health, inc. Investors In recent developments, shareholders of agilon health, inc. (NYSE: AGL) find themselves under scrutiny due to potentially misleading information that may have impacted their investments. The Rosen Law Firm, a respected global investor rights legal firm, is actively investigating these possible securities...
Continue Reading
Crédit Agricole S.A. Announces New Share Buyback Initiative Crédit Agricole S.A. is set to launch an exciting new chapter in its financial journey. The company has received all necessary supervisory approvals to commence a share repurchase program targeting up to 22,886,191 ordinary shares. This initiative is not only a strategic maneuver but also reflects the...
Continue Reading